Budesonide and Requip drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Budesonide (budesonide) and Requip (ropinirole hydrochloride). Common drug interactions include dysphonia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Budesonide and Requip. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

On Jul, 10, 2026

72 people who take Budesonide and Requip together, and have interactions are studied.

Budesonide and Requip drug interactions.

What are the common drug interactions of Budesonide and Requip, by gender? *:

female:

Dysphonia (speech disorder attributable to a disorder of phonation)
Fall
Headache (pain in head)
Hepatic enzyme increased
Herpes virus infection
Injection site pain
Nausea (feeling of having an urge to vomit)
Oedema (fluid collection in tissue)
Pulmonary oedema (fluid accumulation in the lungs)
Renal disorder (kidney disease)

male:

Asthenia (weakness)
Fall
Cardiac failure congestive
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Contusion (a type of hematoma of tissue in which capillaries)
Cough
Defaecation urgency (a sudden compelling urge to defecate)
Diarrhoea
Drug level decreased
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Budesonide and Requip, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Bladder disorder
Chest discomfort
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Dyskinesia (abnormality or impairment of voluntary movement)
Erythema (redness of the skin)
Fall
Fatigue (feeling of tiredness)
Hallucination (an experience involving the perception of something not present)
Head injury

40-49:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Hysterectomy
Lung infection
Pneumonia

50-59:

Urticaria (rash of round, red welts on the skin that itch intensely)
Swelling
Weight increased
Dyspnoea (difficult or laboured respiration)
Herpes virus infection
Oedema (fluid collection in tissue)
Pain
Abdominal pain
Appendicitis (inflammation of the appendix)
Blood iron decreased

60+:

Pneumonia
Asthenia (weakness)
Vomiting
Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
Carbon dioxide increased
Haematocrit decreased
Haemoglobin decreased
Hypoxia (low oxygen in tissues)
Platelet count decreased
Weight decreased

What are the existing conditions these people have? *

Fibromyalgia (a long-term condition which causes pain all over the body): 18 people, 25.00%
Immunodeficiency Common Variable: 6 people, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 8.33%
Pain: 5 people, 6.94%
Neuropathy Peripheral (surface nerve damage): 5 people, 6.94%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 5.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Budesonide and Requip?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously